Saint-Gobain launches T cell-specific cell culture bags

By The Science Advisory Board staff writers

February 26, 2021 -- Saint-Gobain Life Sciences has launched VueLife HP, a new high-permeability cell culture bag designed specifically for T cell-derived therapies.

The product builds on the company's VueLife family of fluorinated ethylene propylene-based cell culture bags. It incorporates a patented laminate film layer that enables increased carbon dioxide and oxygen exchange, compared with other monolayer bag designs, while maintaining the scalability and process flexibility of a closed-bag system, the company said. The increased permeability associated with the laminate layer is intended for culturing cells that require higher rates of respiration, such as T cells.

Saint-Gobain is a material science company that provides solutions for the cell and gene therapy manufacturing industry.

VueLife HP series bag cell culture testing in Saint-Gobain Life Sciences Laboratory
VueLife HP series bag cell culture testing in Saint-Gobain Life Sciences Laboratory. Image courtesy of Saint-Gobain.
New consortium formed to develop cell-based cancer vaccines
A new consortium has been formed to increase access to cell-based cancer vaccines by using single-use technology to develop and manufacture dendritic...

Copyright © 2021

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter